Participate in a Study

Participation in ORION is by invitation only. You will receive an email from us if you are eligible to participate.

If you have received an email from us and do not want to participate, please:

• Click the opt out link in your email;
• Call the study team at: 503-528-3953 or 866-206-2977; or
• Email the study team: CHR_ORION@kpchr.org

If you opt out, we will stop contacting you to participate. If you change your mind about participating, you can still use the link and access code to learn more.

The goal of the ORION study is to better understand how often adults experience stomach illness (also known as acute gastroenteritis or AGE) related to norovirus, which adults are at higher risk for norovirus-associated illness, and how that illness impacts a person’s quality of life.

We are inviting Kaiser Permanente members who are 18 years of age and older, who have not had vomiting or diarrhea in the past 14 days, and who are comfortable reading study materials and talking to study staff in English to take part in this study.

If you meet these criteria, you may receive an email and/or brochure inviting you to participate in the ORION Study. If you do not receive an email from us, you are unable to participate in ORION.

As part of the study, we are asking participants to fill out weekly online surveys for up to 34 weeks and to self-collect a stool sample if they are sick.

As a thank you for taking part in this study, participants will be eligible for up to $125 in Amazon gift codes.

Participation in ARIA is by invitation only. You will receive an email or phone call from us if you are eligible to participate.

If you have received an email from us and do not want to participate, please:

• Click the opt out link in your email;
• Call the study team at: 866- 331-8046 or 503-335- 2493; or
• Email: chr_ariastudy@kpchr.org

We will remove you from our list to avoid getting additional emails.

Kaiser Permanente Researchers want to better understand acute respiratory illness (ARI). Respiratory illness can include coughing, sore throat, and/or sneezing, sometimes called “the flu.” For this research study we want to understand the burden of respiratory illness for our Kaiser members, how it impacts the quality of life and the cost of the illness. What we learn from the ARIA Study will inform the development of efforts to prevent or treat ARI in the future.

We are recruiting Kaiser members who fit the criteria below:

• Kaiser Permanente member
• Recent visit (video, phone, or in-person) at which your doctor noted a diagnosis that may be due to acute respiratory illness.
• We are inviting members who are at home when they received their diagnosis of ARI and members who are in hospital with a diagnosis of ARI.

For people who meet these criteria, we will either email an invitation to members or reach out while they are in hospital. If you have not been contacted by the ARIA study team by email or phone call, you are unable to participate in ARIA.

Participation in Sick Mix is by invitation only. You will receive an email from us if you are eligible to participate.

If you have received an email from us and do not want to participate, please:

• Click the opt out link in your email;
• Call the study team at: 503-528-3962 or 866-206-2976; or
• Email: CHR_Sickmix@kpchr.org

We will remove you from our list to avoid getting additional emails.

The goal of the Sick Mix study is to assess how daily human contact patterns change for people who are sick with acute gastroenteritis (AGE) or acute respiratory illness (ARI) and their household contacts.

We are recruiting Kaiser members who fit the criteria below:

• Kaiser Permanente member
• Recent visit (video, phone, or in-person) at which your doctor noted a diagnosis that may be due to AGE or ARI.

To people who meet these criteria, we will email an invitation to participate in Sick Mix. If you do not receive an email from us, you are unable to participate in Sick Mix.

Contact Study
If you have questions about the study or would like to enroll, please call 1-866-404-0792, or 503-528-3982, or email CHR_H1Dstudy@kpchr.org.

The HPV 1 Dose (H1D) study is looking at the immune response in children who have had one dose of the human papillomavirus (HPV) vaccine. If your child was aged 9 through 12 when they received the vaccine, and received just one dose of the HPV vaccine one to four years ago they may be eligible to take part. The goal of this study is to help us understand if the immune response to one dose of HPV vaccine is similar in females and males.

If you and your child decide to join the study, you will be asked to:

• Complete a web-based survey to see if your child is eligible to join the study
• Complete an in-person or virtual (phone/webinar) visit with study staff to hear more about the study and complete the consent form
• Bring your child to the research clinic to provide a blood sample, or help your child collect blood at home using a device called Tasso+
• Complete a short survey about HPV vaccination

Parents or Guardians will be given a $50 gift card after completion of these events, on behalf of your child. If you decide to have your child’s blood collected in-clinic, we will give you another $25 gift card ($75 total) to help with transportation costs.

Our research clinic is located on the Interstate Campus in North Portland. Limited appointments may also be offered on the Sunnyside Campus in SE Portland.  Or you can choose to complete all study activities from your home.

This study is sponsored by the Centers for Disease Control and Prevention.

The Connect for Cancer Prevention Study wants to better understand the causes of cancer and how to prevent it. Kaiser Permanente Northwest with partner health care systems across the country is partnered with the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), for Connect. The research study will include 200,000 adults who get their health care from a partner health care system.

Participants will be asked to answer online health surveys, donate samples of blood, urine, and saliva, and share access to their electronic health records. This information will help researchers study the health and behavior patterns that may affect cancer risk. It takes time to understand the causes of cancer, so Connect will go on for many years. The longer you participate, the more we may learn.

Find Connect on clinicaltrials.gov

Contact & Location

503-335-6656
877-842-9580 (toll-free)

3800 N. Interstate Ave.
Portland, Or 97227-1098

Do you suffer from insomnia? Do you have prediabetes? If so, you may be eligible to join a research study and receive treatment for insomnia at no cost to you. Scientists at the Kaiser Permanente Center for Health Research are studying whether treating insomnia can help people with prediabetes.

The study, called Sleep for Health, requires 10 visits to the Center for Health Research, located on the Kaiser Permanente campus at 3800 N. Interstate Ave., Portland, Oregon. If you participate, you will be reimbursed for your time and travel expenses.

KP.org/researchbank

By providing a blood sample and completing a survey, Kaiser Permanente members can help researchers understand how our genes, environment, and behavior interact to influence our risk for diseases such as cancer, cardiovascular disease, diabetes, mental illness, and obesity. The goal of the KP Research Bank is to improve the health of our members and your community.

Contact

Ask your doctor if you may be eligible for one of our clinical trials or
call the Oncology Recruitment Office:
503-331-6537

Kaiser Permanente members who have been diagnosed with cancer are eligible to participate in important cancer clinical trials.